Chengdu Easton Bio Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of chemical raw materials and drug preparation. Its products include anti-tumor medicines such as Ubenimex capsules and ibandronate injections; cardiovascular medicines such as bisoprolol fumarate tablets; digestive medicines such as compound glycyrrhizin injections; anesthesia and analgesic products such as nalmefene hydrochloride injections and ibuprofen; and children’s medications. The company was founded by Ying Wang on June 1, 2009 and is headquartered in Chengdu, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company